- Home
- NTGR vs DNTH Comparison
NTGR vs DNTH Comparison
Compare NTGR & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTGR
- DNTH
- Stock Information
- Founded
- NTGR 1996
- DNTH 2015
- Country
- NTGR United States
- DNTH United States
- Employees
- NTGR N/A
- DNTH N/A
- Industry
- NTGR Telecommunications Equipment
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- NTGR Utilities
- DNTH Health Care
- Exchange
- NTGR Nasdaq
- DNTH Nasdaq
- Market Cap
- NTGR 801.8M
- DNTH 711.2M
- IPO Year
- NTGR N/A
- DNTH N/A
- Fundamental
- Price
- NTGR $27.17
- DNTH $20.00
- Analyst Decision
- NTGR Hold
- DNTH Strong Buy
- Analyst Count
- NTGR 1
- DNTH 9
- Target Price
- NTGR $13.00
- DNTH $46.43
- AVG Volume (30 Days)
- NTGR 363.0K
- DNTH 285.9K
- Earning Date
- NTGR 02-05-2025
- DNTH 11-07-2024
- Dividend Yield
- NTGR N/A
- DNTH N/A
- EPS Growth
- NTGR N/A
- DNTH N/A
- EPS
- NTGR 0.66
- DNTH N/A
- Revenue
- NTGR $680,014,000.00
- DNTH $5,366,000.00
- Revenue This Year
- NTGR N/A
- DNTH $100.14
- Revenue Next Year
- NTGR $6.07
- DNTH N/A
- P/E Ratio
- NTGR $41.29
- DNTH N/A
- Revenue Growth
- NTGR N/A
- DNTH 51.41
- 52 Week Low
- NTGR $10.48
- DNTH $11.41
- 52 Week High
- NTGR $31.55
- DNTH $33.77
- Technical
- Relative Strength Index (RSI)
- NTGR 55.72
- DNTH 37.81
- Support Level
- NTGR $25.55
- DNTH $18.35
- Resistance Level
- NTGR $27.25
- DNTH $28.65
- Average True Range (ATR)
- NTGR 0.84
- DNTH 2.23
- MACD
- NTGR -0.20
- DNTH -0.46
- Stochastic Oscillator
- NTGR 46.69
- DNTH 16.02
About NTGR NETGEAR Inc.
Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.